Advancing Smoking Cessation Among Transgender

NCT07099287 | Completed

• 2 other identifiers: FH-077R21CA284313
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

In partnership with a Community Advisory Board, the investigators developed TRANSformá tu salud (Spanish for TRANSform your health), a culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina. This was a single-arm pilot study with 40 TGD individuals who smoke and received TRANSformá tu salud. The investigators assessed the feasibility, acceptability, and preliminary impact of TRANSformá tu salud.

Conditions

Smoking Cessation

Keywords

Smoking Cessation

Outcome Measures

Primary Outcomes (1)

• Percentage of Participants Reporting 7-Day Point Prevalence Smoking Abstinence at Month 3

  Seven-day point prevalence smoking abstinence is defined as no cigarette smoking, not even a puff, during the 7 days prior to the Month 3 assessment. Abstinence will be assessed as a binary outcome (yes or no), and the result will be reported as the percentage of participants who meet this criterion at Month 3.

  Month 3

Study Arms (1)

TRANSform your health

EXPERIMENTAL

A culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina

Behavioral: TRANSform your health

Interventions

TRANSform your health BEHAVIORAL

A culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina

TRANSform your health

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: Transgender and gender diverse individuals
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Eligible individuals self-identified as transgender and gender diverse individuals, were 18 years old or older, smoked at least three days per week, were interested in quitting smoking within the next 30 days, had an active cellphone with WhatsApp®, and were willing to complete two study visits.

You may not qualify if:

• Use of other tobacco products (including e-cigarettes), pregnancy or breast-feeding, plans to move from their current residence in the next six months, and shared residence with a current study participant

Sponsors & Collaborators

• University of Rochester: lead
• National Cancer Institute (NCI): collaborator
• Fundación Huésped: collaborator

Study Sites (1)

Fundación Huésped

Buenos Aires, Argentina

Location

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health Behavior; Behavior

Study Officials

• Francisco Cartujano, MD

  University of Rochester

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor - Department of Public Health Sciences (SMD)

Study Record Dates

• First Submitted: July 25, 2025
• First Posted: August 1, 2025
• Study Start: September 23, 2024
• Primary Completion: February 5, 2025
• Study Completion: February 28, 2025
• Last Updated: August 1, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

AR (1)